ES2529315T5 - Polímeros recombinantes no estructurados y usos de los mismos - Google Patents

Polímeros recombinantes no estructurados y usos de los mismos Download PDF

Info

Publication number
ES2529315T5
ES2529315T5 ES11172812T ES11172812T ES2529315T5 ES 2529315 T5 ES2529315 T5 ES 2529315T5 ES 11172812 T ES11172812 T ES 11172812T ES 11172812 T ES11172812 T ES 11172812T ES 2529315 T5 ES2529315 T5 ES 2529315T5
Authority
ES
Spain
Prior art keywords
unstructured recombinant
recombinant polymers
polymers
unstructured
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11172812T
Other languages
English (en)
Other versions
ES2529315T3 (es
ES2529315T9 (es
Inventor
Volker Schellenberger
Willem P Stemmer
Chia-Wei Wang
Michael D Scholle
Mikhail Popkov
Nathaniel C Gordon
Andreas Crameri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amunix Pharmaceuticals Inc
Original Assignee
Amunix Operating Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/528,950 external-priority patent/US20070212703A1/en
Application filed by Amunix Operating Inc filed Critical Amunix Operating Inc
Publication of ES2529315T3 publication Critical patent/ES2529315T3/es
Publication of ES2529315T9 publication Critical patent/ES2529315T9/es
Application granted granted Critical
Publication of ES2529315T5 publication Critical patent/ES2529315T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
ES11172812T 2006-03-06 2007-03-06 Polímeros recombinantes no estructurados y usos de los mismos Active ES2529315T5 (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US74341006P 2006-03-06 2006-03-06
US743410P 2006-03-06
US74362206P 2006-03-21 2006-03-21
US743622P 2006-03-21
US528950 2006-09-27
US11/528,950 US20070212703A1 (en) 2005-09-27 2006-09-27 Proteinaceous pharmaceuticals and uses thereof
US528927 2006-09-27
US11/528,927 US20070191272A1 (en) 2005-09-27 2006-09-27 Proteinaceous pharmaceuticals and uses thereof

Publications (3)

Publication Number Publication Date
ES2529315T3 ES2529315T3 (es) 2015-02-19
ES2529315T9 ES2529315T9 (es) 2015-05-29
ES2529315T5 true ES2529315T5 (es) 2024-02-23

Family

ID=48527357

Family Applications (2)

Application Number Title Priority Date Filing Date
ES07752636T Active ES2417153T5 (es) 2006-03-06 2007-03-06 Polímeros recombinantes no estructurados y usos de los mismos
ES11172812T Active ES2529315T5 (es) 2006-03-06 2007-03-06 Polímeros recombinantes no estructurados y usos de los mismos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES07752636T Active ES2417153T5 (es) 2006-03-06 2007-03-06 Polímeros recombinantes no estructurados y usos de los mismos

Country Status (7)

Country Link
EP (1) EP2402754B2 (es)
JP (4) JP2013081481A (es)
CN (1) CN103360471B (es)
DK (1) DK1996220T4 (es)
ES (2) ES2417153T5 (es)
FI (2) FI1996220T4 (es)
HK (1) HK1203624A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2573102B1 (en) 2010-01-29 2018-10-03 Archer-Daniels-Midland Company Peptide domains that bind small molecules of industrial significance
WO2014042209A1 (ja) * 2012-09-14 2014-03-20 公益財団法人がん研究会 ＥｐＣＡＭに結合するペプチド
EP2948471A4 (en) * 2013-01-24 2016-08-10 Mayo Foundation METHOD AND MATERIALS FOR DETECTING POSITIVE FRONTOTEMPORAL PAPER DEGENERATION BY C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSION OR AMYOTROPHATE LATERAL SCLEROSIS BY C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSION
CN105985444B (zh) * 2015-02-05 2024-02-13 博生吉安科细胞技术有限公司 一种嵌合抗原受体、以及快速构建嵌合抗原受体的方法及应用
WO2016146174A1 (en) * 2015-03-17 2016-09-22 Biontech Ag Compositions and methods for diagnosis and treatment of cancer
IT201700122135A1 (it) * 2017-10-26 2019-04-26 Jointherapeutics S R L Acido ialuronico funzionalizzato o suo derivato nel trattamento di stati infiammatori
CN108931513B (zh) * 2018-08-28 2021-11-19 河南省医药科学研究院 体外检测MUSK-Ab和LRP4-Ab的方法及试剂盒
AU2019343850B2 (en) * 2018-09-17 2024-06-06 Gi Innovation, Inc. Fusion protein comprising IL-2 protein and CD80 protein, and use thereof
WO2020112647A1 (en) * 2018-11-27 2020-06-04 Khona Scientific Llc Bidirectional multi-enzymatic scaffolds for biosynthesizing cannabinoids
CN111948404B (zh) * 2020-08-03 2023-04-07 融智生物科技（青岛）有限公司 用于筛查地中海贫血的特征蛋白标记组合物、质谱模型及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225449B1 (en) † 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
US20050287153A1 (en) * 2002-06-28 2005-12-29 Genentech, Inc. Serum albumin binding peptides for tumor targeting
US20030049689A1 (en) * 2000-12-14 2003-03-13 Cynthia Edwards Multifunctional polypeptides
US20020169125A1 (en) † 2001-03-21 2002-11-14 Cell Therapeutics, Inc. Recombinant production of polyanionic polymers and uses thereof
US7081446B2 (en) † 2002-01-31 2006-07-25 The Trustees Of Columbia University In The City Of New York Long-acting follicle stimulating hormone analogues and uses thereof
US20040234609A1 (en) † 2003-05-14 2004-11-25 Collier Katherine D. Repeat sequence protein polymer active agent congjugates, methods and uses
JP5735194B2 (ja) † 2005-01-25 2015-06-17 セル セラピューティクス インコーポレーテッド 改善された生体内半減期を有する生物学的に活性なタンパク質
US7855279B2 (en) † 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
ES2779992T3 (es) † 2005-12-20 2020-08-21 Univ Duke Métodos y composiciones para suministrar agentes activos con propiedades farmacológicas potenciadas
WO2008049711A1 (en) † 2006-10-27 2008-05-02 Novo Nordisk A/S Peptide extended insulins

Also Published As

Publication number Publication date
ES2529315T3 (es) 2015-02-19
EP2402754A2 (en) 2012-01-04
JP2015006202A (ja) 2015-01-15
FI1996220T4 (fi) 2023-11-09
HK1203624A1 (en) 2015-10-30
EP2402754B9 (en) 2015-03-11
EP2402754B2 (en) 2023-07-26
JP6175030B2 (ja) 2017-08-02
CN103360471A (zh) 2013-10-23
FI2402754T4 (fi) 2023-10-06
EP2402754A3 (en) 2012-04-18
JP2014198050A (ja) 2014-10-23
JP2016185990A (ja) 2016-10-27
JP2013081481A (ja) 2013-05-09
ES2417153T3 (es) 2013-08-06
DK1996220T4 (da) 2023-11-13
EP2402754B1 (en) 2014-11-19
ES2529315T9 (es) 2015-05-29
DK1996220T3 (da) 2013-07-08
ES2417153T5 (es) 2024-04-04
CN103360471B (zh) 2016-04-27

Similar Documents

Publication Publication Date Title
DK2402754T4 (da) Ustrukturerede rekombinante polymerer og anvendelser deraf
ES2529315T5 (es) Polímeros recombinantes no estructurados y usos de los mismos
DK1833532T3 (da) Sikkerhedssprøjte
BRPI0819909A2 (pt) anticorpos antimesotelina e usos dos mesmos
CL2005002823A1 (es) Anticuerpos anti-virus respiratorio sincitial, antigenos y usos de los mismos
SI1996220T2 (sl) Nestrukturirani rekombinantni polimeri in njihove uporabe
DE602005020054D1 (de) Ophthalmische zusammensetzungen mit polyethersubstituierten polymeren
BRPI0912198A2 (pt) anticorpos anti-fn14 e usos dos mesmos
BRPI0820188A2 (pt) estruturas e métodos concentradores de luz.
BRPI1011404A2 (pt) mutantes e usos dos mesmos
BRPI0908906A2 (pt) compostos heterocíclicos e usos dos mesmos
BRPI0922790A2 (pt) peptídeos de ligação sparc e usos dos mesmos
BRPI1013943A2 (pt) Composto cetais e usos dos mesmos.
DE602005027897D1 (de) Polyhedrisch modifiziertes polymer
BR112012006501A2 (pt) polipeptídios e usos dos mesmos
CR10799A (es) Derivados de metastina y sus usos
BRPI0814599A2 (pt) Pesticidas e usos dos mesmos
BRPI0817269A2 (pt) Análogos de azacitidina e usos dos mesmos
DE602006005220D1 (de) Schaltungssicherheit
DK1989220T3 (da) HIV-fusionsinhibitorpeptider med forbedrede biologiske egenskaber
BRPI0912350A2 (pt) circuito de interface, e, interface
DE602007011008D1 (de) Optische Verbindungsteile und optische Verbindungsstruktur
BRPI0807173A2 (pt) Conjunto de seringa tendo características de prevenção de reutilização
ITMI20060612A1 (it) New activaded poly-ethylene glycols-and related polymers and their applications
DE602005024176D1 (de) Thermoprozessor mit auswechselbarer muffe